Friday, June 19, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 355 of 1,261

  1. US 10959938

    Combination of (3S,3S′) 4,4′-disulfanediylbis(3-aminobutane 1-sulfonic acid) and a second antihypertensive agent

    QUANTUM GENOMICS · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted

  2. US 10961298

    Monoclonal antibodies for treatment of microbial infections

    The Government of the United States, represented by the Secretary of the Army · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted

  3. US 10961305

    Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfecta

    Mereo Biopharma 3 Limited · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted

  4. US 10961297

    BTLA fusion protein agonists and uses thereof

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted

  5. US 10961267

    Prodrugs of a JAK inhibitor compound for treatment of gastrointestinal inflammatory disease

    Theravance Biopharma R&D IP, LLC · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted

  6. US 10961271

    Methods of modulating KEAP1

    Ionis Pharmaceuticals, Inc. · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted

  7. US 10961261

    Oxaborole analogs and uses thereof

    The Government of the United States, as represented by the Secretaryof the Army · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted

  8. US 10959976

    Methods and compositions for treating excessive sleepiness

    Jazz Pharmaceuticals Ireland Limited · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted

  9. US 10961200

    Small molecule inhibitors of lactate dehydrogenase and methods of use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted

  10. US 10960071

    Platform for generating safe cell therapeutics

    The Regents of the University of California · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted

  11. US 10960070

    Prefusion coronavirus spike proteins and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted

  12. US 10960045

    Methods and compositions for the treatment of epidermolysis bullosa

    Compass Therapeutics LLC · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted

  13. US 10960085

    Modulation of liver genes

    Sangamo Therapeutics, Inc. · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted

  14. US 10960051

    Methods of treating dry eye syndrome

    REGENTREE, LLC · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted

  15. US 10960046

    Method of treating melanocortin-4 receptor pathway-associated disorders

    RHYTHM PHARMACEUTICALS, INC. · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted

  16. US 10960016

    Capsules containing high doses of krill phospholipids

    AKER BIOMARINE ANTARCTIC AS · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted

  17. US 10960000

    Abuse resistant pharmaceutical compositions

    RECRO GAINESVILLE LLC · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted

  18. US 10961232

    Substituted pyrazines as ATR kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted

  19. US 10959988

    Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid for the treatment of disease

    PTC THERAPEUTICS, INC. · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted

  20. US 10960029

    Devices and methods for umbilical cord processing

    The Board of Regents of the University of Texas System · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted

  21. US 10959956

    Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances

    Jazz Pharmaceuticals, Inc. · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted

  22. US 10961535

    Compositions and agents against hepatitis B virus and uses thereof

    ARCTURUS THERAPEUTICS, INC. · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted

  23. US 10961238

    Modulators of hedgehog (Hh) signaling pathway

    E-Therapeutics PLC · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted

  24. US 10959952

    Use of exosomes for the treatment of disease

    The Board of Regents of the University of Texas System · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.